Exenatide Acetate (141732-76-5)
Product Summary
Exenatide Acetate (141732-76-5): High-purity (≥98% HPLC) white powder GLP-1 agonist for type 2 diabetes research. Mimics GLP-1 to regulate insulin, glucagon, and appetite. Patent-protected for R&D use.
Product Custom Attributes
Product Description
Exenatide Acetate is a peptide-based drug used for the treatment of type 2 diabetes. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists. By mimicking the effects of GLP-1, it promotes insulin secretion in a glucose-dependent manner, inhibits glucagon release, delays gastric emptying, and reduces appetite, thereby helping to control blood sugar levels.
*The product under patent is only for R&D use.
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.